Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation "sifap2"


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- Adult patients (18 - 55 years of age) with an acute cerebrovascular event (CVE) of any etiology defined as patients having an ischemic stroke or transient ischemic attack
- Genetic diagnosis (a-galactosidase defect)of Fabry disease
- Written informed consent from patient

Exclusion Criteria

- No proven Fabry disease
- Participating in an other clinical trial with any investigational new drug or medical device
- Contraindication to any of the diagnostic procedures like e.g. MRI investigation
- Patient has been pretreated with Enzyme Replacement Therapy at the date of informed consent of sifap2